Crop Protection Pesticide

Global Guide of Coming Off-patent Agrochemical Active Ingredients (2017 version)

Aug 02 2017 Pages: 120 Language: English Price: $2160

Favorites Comment

Forward

: Kcomber, Inc.

With over 15-year development, CCMs research in Agriculture ...

Summary
Table of contents

As a good guide for pesticide companies who are interested in commercial development of coming off-patent products, this report is CCM's fourth edition report on coming off-patent agrochemicals in the world.

This report contains profiles of 34 active ingredients (15 herbicides, 7 insecticides, 11 fungicides and 1 safener), whose patents will be expired in 2017–2022. The coming off-patent active ingredients are expected to add value to the pesticide market. Compared with developing new varieties of pesticides, to develop the pesticides whose patent have been expired will not only cost less and have lower risk, but also enjoy considerable profits. In a word, it will be a huge market with tremendous commercial value.

In this report, CCM focuses on the information of the patent products including
--basic information
--history
--synthesis route
--application
--physical & safety data
--patent information
--registration information

Readers of this report can:

- gain an overview of the coming off-patent products whose patents will be expired in 2017–2022;

- know the registration situation of the hot products of agricultural giants in main agricultural countries.

	Executive summary
	Methodology and scope
1	Profiles of coming off-patent herbicides
1.1	Aminopyralid
1.2	Flucetosulfuron
1.3	Flufenpyr-ethyl
1.4	Foramsulfuron
1.5	Metamifop
1.6	Orthosulfamuron
1.7	Penoxsulam
1.8	Pinoxaden
1.9	Pyrasulfotole
1.10	Pyroxasulfone
1.11	Pyroxsulam
1.12	Saflufenacil
1.13	Tembotrione
1.14	Thiencarbazone-methyl
1.15	Topramezone
2	Profiles of coming off-patent insecticides
2.1	Bistrifluron
2.2	Chlorantraniliprole
2.3	Clothianidin
2.4	Flubendiamide
2.5	Metofluthrin
2.6	Pyrifluquinazon
2.7	Spirotetramat
3	Profiles of coming off-patent fungicides
3.1	Amisulbrom
3.2	Benalaxyl-M
3.3	Fenpyrazamine
3.4	Fluopicolide
3.5	Fluoxastrobin
3.6	Isotianil
3.7	Mandipropamid
3.8	Metalaxyl-M
3.9	Metrafenone
3.10	Penflufen
3.11	Valifenalate
4	Others
4.1	Cyprosulfamide

Table 1.1-1 Patent information of aminopyralid in some countries/regions, as of July 2017

Table 1.1-2 Registration information of aminopyralid in China, as of July 2017

Table 1.1-3 Registration information of aminopyralid in Finland, as of July 2017

Table 1.1-4 Registration information of aminopyralid in Denmark, as of July 2017

Table 1.1-5 Registration information of aminopyralid in Canada, as of July 2017

Table 1.1-6 Registration information of aminopyralid in France, as of July 2017

Table 1.1-7 Registration information of aminopyralid in Uruguay, as of July 2017

Table 1.1-8 Registration information of aminopyralid in Australia, as of July 2017

Table 1.1-9 Registration information of aminopyralid in Switzerland, as of July 2017

Table 1.1-10 Registration information of aminopyralid in Argentina, as of July 2017

Table 1.1-11 Registration information of aminopyralid in South Africa, as of July 2017

Table 1.2-1 Patent information of flucetosulfuron in some countries/regions, as of July 2017

Table 1.2-2 Registration information of flucetosulfuron in China, as of July 2017

Table 1.3-1 Patent information of flufenpyr-ethyl in some countries/regions, as of July 2017

Table 1.4-1 Patent information of foramsulfuron in some countries/regions, as of July 2017

Table 1.4-2 Registration information of foramsulfuron in Argentina, as of July 2017

Table 1.4-3 Registration information of foramsulfuron in Denmark, as of July 2017

Table 1.4-4 Registration information of foramsulfuron in Australia, as of July 2017

Table 1.4-5 Registration information of foramsulfuron in Belgium, as of July 2017

Table 1.4-6 Registration information of foramsulfuron in Canada, as of July 2017

Table 1.4-7 Registration information of foramsulfuron in Chile, as of July 2017

Table 1.4-8 Registration information of foramsulfuron in France, as of July 2017

Table 1.4-9 Registration information of foramsulfuron in Greece, as of July 2017

Table 1.4-10 Registration information of foramsulfuron in the Netherlands, as of July 2017

Table 1.4-11 Registration information of foramsulfuron in Switzerland, as of July 2017

Table 1.4-12 Registration information of foramsulfuron in Uruguay, as of July 2017

Table 1.5-1 Patent information of metamifop in some countries/regions, as of July 2017

Table 1.5-2 Registration information of metamifop in China, as of July 2017

Table 1.5-3 Registration information of metamifop in Uruguay, as of July 2017

Table 1.6-1 Patent information of orthosulfamuron in some countries/regions, as of July 2017

Table 1.6-2 Registration information of orthosulfamuron in China, as of July 2017

Table 1.6-3 Registration information of orthosulfamuron in Brazil, as of July 2017

Table 1.7-1 Patent information of penoxsulam in some countries/regions, as of July 2017

Table 1.7-2 Registration information of penoxsulam in Argentina, as of July 2017

Table 1.7-3 Registration information of penoxsulam in Brazil, as of July 2017

Table 1.7-4 Registration information of penoxsulam in Chile, as of July 2017

Table 1.7-5 Registration information of penoxsulam in China, as of July 2017

Table 1.7-6 Registration information of penoxsulam in France, as of July 2017

Table 1.7-7 Registration information of penoxsulam in Switzerland, as of July 2017

Table 1.7-8 Registration information of penoxsulam in Uruguay, as of July 2017

Table 1.8-1 Patent information of pinoxaden in some countries/regions, as of July 2017

Table 1.8-2 Registration information of pinoxaden in Argentina, as of July 2017

Table 1.8-3 Registration information of pinoxaden in South Africa, as of July 2017

Table 1.8-4 Registration information of pinoxaden in Australia, as of July 2017

Table 1.8-5 Registration information of pinoxaden in Belgium, as of July 2017

Table 1.8-6 Registration information of pinoxaden in Canada, as of July 2017

Table 1.8-7 Registration information of pinoxaden in Chile, as of July 2017

Table 1.8-8 Registration information of pinoxaden in China, as of July 2017

Table 1.8-9 Registration information of pinoxaden in Finland, as of July 2017

Table 1.8-10 Registration information of pinoxaden in France, as of July 2017

Table 1.8-11 Registration information of pinoxaden in the Netherlands, as of July 2017

Table 1.8-12 Registration information of pinoxaden in Switzerland, as of July 2017

Table 1.8-13 Registration information of pinoxaden in Uruguay, as of July 2017

Table 1.9-1 Patent information of pyrasulfotole in some countries/regions, as of July 2017

Table 1.9-2 Registration information of pyrasulfotole in Canada, as of July 2017

Table 1.9-3 Registration information of pyrasulfotole in Australia, as of July 2017

Table 1.9-4 Registration information of pyrasulfotole in South Africa, as of July 2017

Table 1.10-1 Patent information of pyroxasulfone in some countries/regions, as of July 2017

Table 1.10-2 Registration information of pyroxasulfone in Canada, as of July 2017

Table 1.10-3 Registration information of pyroxasulfone in Australia, as of July 2017

Table 1.10-4 Registration information of pyroxasulfone in South Africa, as of July 2017

Table 1.11-1 Patent information of pyroxsulam in some countries/regions, as of July 2017

Table 1.11-2 Registration information of pyroxsulam in China, as of July 2017

Table 1.11-3 Registration information of pyroxsulam in Belgium, as of July 2017

Table 1.11-4 Registration information of pyroxsulam in Brazil, as of July 2017

Table 1.11-5 Registration information of pyroxsulam in Canada, as of July 2017

Table 1.11-6 Registration information of pyroxsulam in France, as of July 2017

Table 1.11-7 Registration information of pyroxsulam in the Netherlands, as of July 2017

Table 1.11-8 Registration information of pyroxsulam in Australia, as of July 2017

Table 1.11-9 Registration information of pyroxsulam in Switzerland, as of July 2017

Table 1.11-10 Registration information of pyroxsulam in Denmark, as of July 2017

Table 1.11-11 Registration information of pyroxsulam in Greece, as of July 2017

Table 1.11-12 Registration information of pyroxsulam in South Africa, as of July 2017

Table 1.12-1 Patent information of saflufenacil in some countries/regions, as of July 2017

Table 1.12-2 Registration information of saflufenacil in China, as of July 2017

Table 1.12-3 Registration information of saflufenacil in Brazil, as of July 2017

Table 1.12-4 Registration information of saflufenacil in Canada, as of July 2017

Table 1.12-5 Registration information of saflufenacil in Uruguay, as of July 2017

Table 1.12-6 Registration information of saflufenacil in Australia, as of July 2017

Table 1.12-7 Registration information of saflufenacil in Chile, as of July 2017

Table 1.12-8 Registration information of saflufenacil in Argentina, as of July 2017

Table 1.13-1 Patent information of tembotrione in some countries/regions, as of July 2017

Table 1.13-2 Registration information of tembotrione in Belgium, as of July 2017

Table 1.13-3 Registration information of tembotrione in South Africa, as of July 2017

Table 1.13-4 Registration information of tembotrione in Canada, as of July 2017

Table 1.13-5 Registration information of tembotrione in Chile, as of July 2017

Table 1.13-6 Registration information of tembotrione in France, as of July 2017

Table 1.13-7 Registration information of tembotrione in the Netherlands, as of July 2017

Table 1.13-8 Registration information of tembotrione in Switzerland, as of July 2017

Table 1.14-1 Patent information of thiencarbazone-methyl in some countries/regions, as of July 2017

Table 1.14-2 Registration information of thiencarbazone-methyl in Belgium, as of July 2017

Table 1.14-3 Registration information of thiencarbazone-methyl in Canada, as of July 2017

Table 1.14-4 Registration information of thiencarbazone-methyl in France, as of July 2017

Table 1.14-5 Registration information of thiencarbazone-methyl in the Netherlands, as of July 2017

Table 1.14-6 Registration information of thiencarbazone-methyl in Uruguay, as of July 2017

Table 1.14-7 Registration information of thiencarbazone-methyl in China, as of July 2017

Table 1.15-1 Patent information of topramezone in some countries/regions, as of July 2017

Table 1.15-2 Registration information of topramezone in Argentina, as of July 2017

Table 1.15-3 Registration information of topramezone in South Africa, as of July 2017

Table 1.15-4 Registration information of topramezone in Canada, as of July 2017

Table 1.15-5 Registration information of topramezone in Chile, as of July 2017

Table 1.15-6 Registration information of topramezone in China, as of July 2017

Table 1.15-7 Registration information of topramezone in Australia, as of July 2017

Table 2.1-1 Patent information of bistrifluron in some countries/regions, as of July 2017

Table 2.1-2 Registration information of bistrifluron in Australia, as of July 2017

Table 2.1-3 Registration information of bistrifluron in Argentina, as of July 2017

Table 2.2-1 Patent information of chlorantraniliprole in some countries/regions, as of July 2017

Table 2.2-2 Registration information of chlorantraniliprole in China, as of July 2017

Table 2.2-3 Registration information of chlorantraniliprole in Canada, as of July 2017

Table 2.2-4 Registration information of chlorantraniliprole in France, as of July 2017

Table 2.2-5 Registration information of chlorantraniliprole in the Netherlands, as of July 2017

Table 2.2-6 Registration information of chlorantraniliprole in Australia, as of July 2017

Table 2.2-7 Registration information of chlorantraniliprole in Switzerland, as of July 2017

Table 2.2-8 Registration information of chlorantraniliprole in South Africa, as of July 2017

Table 2.3-1 Patent information of clothianidin in some countries/regions, as of July 2017

Table 2.3-2 Registration information of clothianidin in Chile, as of July 2017

Table 2.3-3 Registration information of clothianidin in Denmark, as of July 2017

Table 2.3-4 Registration information of clothianidin in South Africa, as of July 2017

Table 2.3-5 Registration information of clothianidin in Australia, as of July 2017

Table 2.3-6 Registration information of clothianidin in Belgium, as of July 2017

Table 2.3-7 Registration information of clothianidin in Canada, as of July 2017

Table 2.3-8 Registration information of clothianidin in China, as of July 2017

Table 2.3-9 Registration information of clothianidin in Greece, as of July 2017

Table 2.3-10 Registration information of clothianidin in the Netherlands, as of July 2017

Table 2.3-11 Registration information of clothianidin in Switzerland, as of July 2017

Table 2.3-12 Registration information of clothianidin in Uruguay, as of July 2017

Table 2.3-13 Registration information of clothianidin in France, as of July 2017

Table 2.4-1 Patent information of flubendiamide in some countries/regions, as of July 2017

Table 2.4-2 Registration information of flubendiamide in Argentina, as of July 2017

Table 2.4-3 Registration information of flubendiamide in Australia, as of July 2017

Table 2.4-4 Registration information of flubendiamide in South Africa, as of July 2017

Table 2.4-5 Registration information of flubendiamide in Chile, as of July 2017

Table 2.4-6 Registration information of flubendiamide in China, as of July 2017

Table 3.8-8 Registration information of metalaxyl-M in Brazil, as of July 2017

Table 3.8-9 Registration information of metalaxyl-M in Canada, as of July 2017

Table 3.8-10 Registration information of metalaxyl-M in China, as of July 2017

Table 3.8-11 Registration information of metalaxyl-M in Finland, as of July 2017

Table 3.8-12 Registration information of metalaxyl-M in Greece, as of July 2017

Table 3.8-13 Registration information of metalaxyl-M in the Netherlands, as of July 2017

Table 3.8-14 Registration information of metalaxyl-M in Switzerland, as of July 2017

Table 3.8-15 Registration information of metalaxyl-M in Uruguay, as of July 2017

Table 3.8-16 Registration information of metalaxyl-M in France, as of July 2017

Table 3.9-1 Patent information of metrafenone in some countries/regions, as of July 2017

Table 3.9-2 Registration information of metrafenone in Australia, as of July 2017

Table 3.9-3 Registration information of metrafenone in Argentina, as of July 2017

Table 3.9-4 Registration information of metrafenone in Denmark, as of July 2017

Table 3.9-5 Registration information of metrafenone in South Africa, as of July 2017

Table 3.9-6 Registration information of metrafenone in Belgium, as of July 2017

Table 3.9-7 Registration information of metrafenone in Canada, as of July 2017

Table 3.9-8 Registration information of metrafenone in Chile, as of July 2017

Table 3.9-9 Registration information of metrafenone in Switzerland, as of July 2017

Table 3.9-10 Registration information of metrafenone in China, as of July 2017

Table 3.9-11 Registration information of metrafenone in the Netherlands, as of July 2017

Table 3.9-12 Registration information of metrafenone in France, as of July 2017

Table 3.10-1 Patent information of penflufen in some countries/regions, as of July 2017

Table 3.10-2 Registration information of penflufen in China, as of July 2017

Table 3.10-3 Registration information of penflufen in Canada, as of July 2017

Table 3.10-4 Registration information of penflufen in the Netherlands, as of July 2017

Table 3.10-5 Registration information of penflufen in Australia, as of July 2017

Table 3.11-1 Patent information of valifenalate in some countries/regions, as of July 2017

Table 3.11-2 Registration information of valifenalate in Belgium, as of July 2017

Table 3.11-3 Registration information of valifenalate in France, as of July 2017

Table 3.11-4 Registration information of valifenalate in Switzerland, as of July 2017

Table 4.1-1 Patent information of cyprosulfamide in some countries/regions, as of July 2017

Table 4.1-2 Registration information of cyprosulfamide in Belgium, as of July 2017

Table 4.1-3 Registration information of cyprosulfamide in Canada, as of July 2017

Table 4.1-4 Registration information of cyprosulfamide in Uruguay, as of July 2017

Table 4.1-5 Registration information of cyprosulfamide in Argentina, as of July 2017

Figure 1.1-1 Chemical structure of aminopyralid

Figure 1.2-1 Chemical structure of flucetosulfuron

Figure 1.2-2 Route for synthesizing flucetosulfuron

Figure 1.3-1 Chemical structure of flufenpyr-ethyl

Figure 1.3-2 Route for synthesizing flufenpyr-ethyl

Figure 1.4-1 Chemical structure of foramsulfuron

Figure 1.4-2 Route A for synthesizing foramsulfuron

Figure 1.4-3 Route B for synthesizing foramsulfuron

Figure 1.4-4 Route C for synthesizing foramsulfuron

Figure 1.4-5 Route D for synthesizing foramsulfuron

Figure 1.5-1 Chemical structure of metamifop

Figure 1.5-2 Route A for synthesizing metamifop

Figure 1.5-3 Route B for synthesizing metamifop

Figure 1.5-4 Route C for synthesizing metamifop

Figure 1.6-1 Chemical structure of orthosulfamuron

Figure 1.6-2 Route A for synthesizing orthosulfamuron

Figure 1.6-3 Route B for synthesizing orthosulfamuron

Figure 1.7-1 Chemical structure of penoxsulam

Figure 1.7-2 Route A for synthesizing penoxsulam

Figure 1.7-3 Route B for synthesizing penoxsulam

Figure 1.8-1 Chemical structure of pinoxaden

Figure 1.8-2 Route for synthesizing pinoxaden

Figure 1.9-1 Chemical structure of pyrasulfotole

Figure 1.10-1 Chemical structure of Pyroxasulfone

Figure 1.11-1 Chemical structure of pyroxsulam

Figure 1.12-1 Chemical structure of saflufenacil

Figure 1.13-1 Chemical structure of tembotrione

Figure 1.13-2 Route for synthesizing tembotrione

Figure 1.14-1 Chemical structure of thiencarbazone-methyl

Figure 1.15-1 Chemical structure of topramezone

Figure 1.15-2 Route for synthesizing topramezone

Figure 2.1-1 Chemical structure of bistrifluron

Figure 2.1-2 Route for synthesizing bistrifluron

Figure 2.2-1 Chemical structure of chlorantraniliprole

Figure 2.3-1 Chemical structure of clothianidin

Figure 2.3-2 Route A for synthesizing clothianidin

Figure 2.3-3 Route B for synthesizing clothianidin

Figure 2.3-4 Route C for synthesizing clothianidin

Figure 2.3-5 Route D for synthesizing clothianidin

Figure 2.4-1 Chemical structure of flubendiamide

Figure 2.5-1 Chemical structure of metofluthrin

Figure 2.5-2 Route for synthesizing metofluthrin

Figure 2.6-1 Chemical structure of pyrifluquinazon

Figure 2.7-1 Chemical structure of spirotetramat

Figure 2.7-2 Route for synthesizing spirotetramat

Figure 3.1-1 Chemical structure of amisulbrom

Figure 3.2-1 Chemical structure of benalaxyl-M

Figure 3.2-2 Route A for synthesizing benalaxyl-M

Figure 3.2-3 Route B for synthesizing benalaxyl-M

Figure 3.3-1 Chemical structure of fenpyrazamine

Figure 3.4-1 Chemical structure of fluopicolide

Figure 3.4-2 Route A for synthesizing fluopicolide

Figure 3.4-3 Route B for synthesizing fluopicolide

Figure 3.5-1 Chemical structure of fluoxastrobin

Figure 3.5-2 Route A for synthesizing fluoxastrobin

Figure 3.5-3 Route B for synthesizing fluoxastrobin

Figure 3.6-1 Chemical structure of isotianil

Figure 3.6-2 Route for synthesizing isotianil

Figure 3.7-1 Chemical structure of mandipropamid

Figure 3.8-1 Chemical structure of metalaxyl-M

Figure 3.8-2 Route A for synthesizing metalaxyl-M

Figure 3.8-3 Route B for synthesizing metalaxyl-M

Figure 3.9-1 Chemical structure of metrafenone

Figure 3.9-2 Route for synthesizing metrafenone

Figure 3.10-1 Chemical structure of penflufen

Figure 3.11-1 Chemical structure of valifenalate

Figure 4.1-1 Chemical structure of cyprosulfamide

ECPA Statistical Review 2012（for free）

2014-01-06 Pages:45 Language: English Publisher: Croplife Europe (European Crop Protection Association)

Free
The contribution of glyphosate to agriculture and potential impact of restrictions on use at the g...

2017-12-18 Pages:14 Language: English Publisher: christina

Free
Dicamba Herbicide Market by Crop Type (Cereals & Grains, Oilseeds & Pulses, and Pastures & Forage ...

2016-11-21 Pages:135 Language: English Publisher: MarketsandMarkets Research Private Limited

Free
Bensulfuron-methyl WG - ICAMA Registration Report

2011-05-23 Pages:0 Language: English Publisher: AgroPages

Free
INDIAN AGROCHEMICALS INDUSTRY DATABASE 2018

2018-04-28 Pages:980 Language: English Publisher: Komal Publication

Free
Top 400 Agricultural Chemical Manufacturers (Global)

2013-03-13 Pages:505 Language: English Publisher: Plimsoll Publishing Ltd

Free
Survey of Metolachlor in China

2018-11-28 Pages:29 Language: English Publisher: Kcomber, Inc.

Free
Agchem Products Registration Information of Argentina

2016-10-26 Pages:0 Language: English Publisher: AgroPages

Free

Upload my report

Total 2,228 documents

Region All

China(208) Germany(5) India(78) Japan(15) Russia(10) Thailand(11) United States(74) Asia(283) Europe(109) North America(79) Association of Southeast Asian Nations(32) Global(1150)

Industry All

Agriculture(333) Adjuvant(28) Acaricide(9) Agricultural Dye & Pigment(8) Biofertilizer(44) Biostimulant(25) Biocontrol(32) Biocontrol(32) Biopesticide(128) Biocide(14) Crop Protection(156) Formulation(28)

All Category

Hot Reports More

Download

Call for papers - BioEx 2025Event

2024 India Focus published!Magazine

Call for Papers— 5th Ag Formulation & Application Technology Congress(FAT 2024) Event

Philippines Agrochemical Products Import Report -2020

Profile of Coming Off-Patent Agrochemicals in 2017-2027

New Off-Patent/Generic Active Ingredients and Mixture Products--Post...

Global Guide of Coming Off-patent Agrochemical Active Ingredients (2017 version)

Kcomber, Inc.

You might also like

ECPA Statistical Review 2012（for free）

The contribution of glyphosate to agriculture and potential impact of restrictions on use at the g...

Dicamba Herbicide Market by Crop Type (Cereals & Grains, Oilseeds & Pulses, and Pastures & Forage ...

Bensulfuron-methyl WG - ICAMA Registration Report

INDIAN AGROCHEMICALS INDUSTRY DATABASE 2018

Top 400 Agricultural Chemical Manufacturers (Global)

Survey of Metolachlor in China

Agchem Products Registration Information of Argentina

Region All

Industry All

Hot Reports More